Carson Wealth (CWM LLC)’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.65M Sell
124,804
-166
-0.1% -$3.32K 0.01% 1077
2025
Q4
$2.04M Sell
124,970
-834
-0.7% -$12.6K 0.01% 1142
2025
Q3
$1.47M Sell
125,804
-6,706
-5% -$87.4K ﹤0.01% 1228
2025
Q2
$1.53M Buy
132,510
+83,604
+171% +$762K 0.01% 1049
2025
Q1
$427K Buy
48,906
+25,868
+112% +$326K ﹤0.01% 1521
2024
Q4
$331K Buy
23,038
+228
+1% +$3.6K ﹤0.01% 1536
2024
Q3
$515K Buy
22,810
+18,621
+445% +$385K ﹤0.01% 1304
2024
Q2
$81K Sell
4,189
-44,067
-91% -$1.15M ﹤0.01% 2125
2024
Q1
$1.81M Sell
48,256
-11,487
-19% -$505K 0.01% 653
2023
Q4
$3.34M Sell
59,743
-3,418
-5% -$149K 0.02% 471
2023
Q3
$2.6M Sell
63,161
-2,302
-4% -$120K 0.02% 491
2023
Q2
$3.65M Sell
65,463
-3,677
-5% -$199K 0.02% 410
2023
Q1
$3.86M Buy
69,140
+67,955
+5,735% +$3.17M 0.03% 373
2022
Q4
$43K Buy
1,185
+389
+49% +$12.7K ﹤0.01% 1829
2022
Q3
$23K Buy
796
+339
+74% +$12.9K ﹤0.01% 2149
2022
Q2
$21K Sell
457
-6,755
-94% -$350K ﹤0.01% 2093
2022
Q1
$549K Sell
7,212
-984
-12% -$86.1K ﹤0.01% 704
2021
Q4
$1.22M Buy
+8,196
New +$1.26M 0.01% 534

Other funds holding TXG

Carson Wealth (CWM LLC)'s TXG Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its 10x Genomics (TXG) stake by 0.13% in Q1 2026, selling an estimated $3.32K and leaving 124,804 shares worth $2.65M. The position accounts for 0.01% of the portfolio, ranked #1077.

Carson Wealth (CWM LLC) first reported a position in TXG in Q4 2021 and has held it in 18 quarters since. The position peaked at $3.86M in Q1 2023. 330 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Carson Wealth (CWM LLC) held 124,804 shares of 10x Genomics worth $2.65M as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 166 10x Genomics shares in Q1 2026, an estimated $3.32K.
  • 10x Genomics made up 0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #1077 holding.
  • Carson Wealth (CWM LLC) first reported a position in 10x Genomics in Q4 2021 and has held it in 18 quarters since.
  • Carson Wealth (CWM LLC)'s 10x Genomics position peaked at $3.86M in Q1 2023.
  • 330 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.